QSAM — Qsam Biosciences Share News
0.000.00%
Brief: Qsam Biosciences Says Co Granted Telix An Additional 30 Days Under Exclusivity Period To Complete Its Due Diligence
Brief: Qsam Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals Receives $2 Million Pre-Closing Collaboration And Option Fee
Brief: Telix Pharmaceuticals Announces Proposed Acquisition Of QSAM Biosciences
Brief: Qsam Biosciences Provides Update To Shareholders On Phase 1 Progress And Preliminary Clinical Data
Brief: QSAM Biosciences Reports Reverse Stock Split Effective March 10, 2022
Brief: QSAM Biosciences Says Has Applied To List Common Stock On Nasdaq
Brief: Q2Earth signs agreement to buy major Florida soil manufacturer, Environmental Turnkey Solutions